The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDukemount Capi. Regulatory News (DKE)

Share Price Information for Dukemount Capi. (DKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.031
Bid: 0.027
Ask: 0.035
Change: 0.00 (0.00%)
Spread: 0.008 (29.63%)
Open: 0.031
High: 0.031
Low: 0.031
Prev. Close: 0.031
DKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed lifting of suspension and other updates

12 Sep 2023 07:44

RNS Number : 1429M
Dukemount Capital PLC
12 September 2023
 

Dukemount Capital Plc

 ("Dukemount" or the "Company")

Proposed lifting of suspension

Further funding

Change to accounting reference date

The board of directors of Dukemount have been in discussions with the FCA following the suspension of the trading of the share capital on the Main Market on 1 November 2022. During this period the audit for 30 April 2022 has been finalised.

 

The shares of Dukemount are anticipated to re-commence trading on 13 September 2023.

 

Following the designation of the Company as a SPAC the directors confirm they will be working with its broker, Peterhouse Capital Limited ("Peterhouse"), and the other advisors to the Company to consider options for a future reverse takeover involving Dukemount. It should be noted, following the changes to the Main Market, any reverse takeover requires as a minimum enlarged market capitalisation of £30 million and there can be no guarantee that such a transaction can be undertaken.

 

The directors have resolved to extend the accounting reference date of Dukemount from 30 April to 30 September. The previous accounts for 30 April 2022 were announced on 9 June 2023 and the interims for the period ending 31 October 2022 (which encompasses the prior disposal of the peakers as announced on 5 October 2022) were announced on 16 June 2023. The accounts for the period ending 30 September 2023 will be published no later than by 31 January 2024.

 

The directors have continued to take steps to reduce the costs incurred by the Company and are taking steps to best ensure the viability of any future transaction by exploring further funding into the Company alongside the appointed broker to enable the 2023 accounts to contain an auditor going concern statement that is not qualified. In the meantime, on 11 September 2023 the board elected to drawdown an additional £40,000 net proceeds from the previously announced long-term facility on 11 October 2022 to provide further capital for on-going costs.

 

 

Paul Gazzard CEO, comments "the process of lifting the suspension of the trading of the shares has taken time. This time has been spent enabling us to move to reposition Dukemount in a manner beneficial for stakeholders as a whole. The Board will now set about searching for a new target company and business to pursue as we repurpose Dukemount and will work with Peterhouse and our other advisors to facilitate this. This process will commence and be undertaken expeditiously and we hope to update the market soon on the next steps for Dukemount."

  

Market Abuse Regulation (MAR) disclosure

 

Certain statements in this announcement contain inside information for the purpose of Article 7 of EU Regulation 596/2014.

 

For further information, please visit www.dukemountcapitalplc.com or contact:

 

Dukemount Capital Plc

Geoffrey Dart Paul Gazzard

Media Enquiries

 

Miriad Media, Zak Mir

Tel: +44 (0)7867 527 659

 

 

Broker Enquiries - Peterhouse Capital Limited

 

Lucy Williams / Duncan Vasey

Tel: +44 (0) 207 4690930

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRQLLBFXKLXBBV
Date   Source Headline
18th Apr 20243:09 pmRNSResult of AGM
21st Mar 20247:00 amRNSNotice of AGM and a conditional subscription
8th Mar 20244:29 pmRNSTR-1: Standard form notification of major holdings
7th Mar 202410:51 amRNSUpdate on the Facility Agreement and TVR
5th Mar 202412:45 pmRNSHolding(s) in Company
4th Mar 20241:16 pmRNSCapitalisation of Loan, Issue of Equity & Warrants
26th Feb 202410:04 amRNSHolding(s) in Company
30th Jan 202412:09 pmRNSFinal Results
12th Jan 20242:13 pmRNSResult of AGM
14th Dec 20239:56 amRNSNotice of AGM
12th Sep 20237:44 amRNSProposed lifting of suspension and other updates
16th Jun 20237:00 amRNSHalf-year Report
9th Jun 202310:17 amRNSFinal Results
22nd Nov 20227:06 amRNSChange of Broker
1st Nov 20228:03 amRNSTemporary Suspension
28th Oct 20224:40 pmRNSSecond Price Monitoring Extn
28th Oct 20224:35 pmRNSPrice Monitoring Extension
28th Oct 20229:32 amRNSIssue of Equity
27th Oct 20224:41 pmRNSSecond Price Monitoring Extn
27th Oct 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20229:32 amRNSIssue of Equity
20th Oct 20229:26 amRNSIssue of Equity
19th Oct 202212:33 pmRNSHolding(s) in Company
19th Oct 20227:00 amRNSHolding(s) in Company
13th Oct 20222:05 pmRNSSecond Price Monitoring Extn
13th Oct 20222:00 pmRNSPrice Monitoring Extension
13th Oct 202211:05 amRNSSecond Price Monitoring Extn
13th Oct 202211:00 amRNSPrice Monitoring Extension
12th Oct 20227:00 amRNSIssue of Equity
11th Oct 20227:00 amRNSFurther Funding and Funding Restructuring
5th Oct 20229:05 amRNSSecond Price Monitoring Extn
5th Oct 20229:00 amRNSPrice Monitoring Extension
5th Oct 20227:20 amRNSCompletion of sale
23rd Feb 20224:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:35 pmRNSPrice Monitoring Extension
28th Jan 20221:43 pmRNSInterim Results
4th Jan 20224:36 pmRNSHolding(s) in Company
29th Oct 20212:16 pmRNSFinal Results
7th Oct 202110:08 amRNSChange of Broker
4th Oct 20217:19 amRNSCompletion of Purchase of Energy Generation Sites
27th Sep 202110:44 amRNSHolding(s) in Company
15th Sep 20217:32 amRNSCompletion of Gas Peaking Funding
17th Aug 202110:55 amRNSHolding(s) in Company
10th Aug 202110:03 amRNSUpdate Re Funding
19th Jul 20217:00 amRNSHolding(s) in Company
19th Jul 20217:00 amRNSHolding(s) in Company
15th Jul 202111:19 amRNSResult of GM
30th Jun 20212:06 pmRNSSecond Price Monitoring Extn
30th Jun 20212:00 pmRNSPrice Monitoring Extension
29th Jun 20213:42 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.